Elan Corporation, plc (ELN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (3449)	10/28/2002 5:26:33 PM
From: arnie h	of 10345

Re: Prialt. An approvable letter for Prialt was received in March 2000. Then in January 2002, we learned, in response to a question in a conference call, they needed to start a new 18 month trial. At no time has the company ever put out a significant PR describing what the issues are and why any trial is needed let alone one taking 18 months. I did read from another source that over 1/3 of of the patients in the Ziconotide trials dropped out due to memory problems and unsteadiness. Apparently, the FDA wasn't happy with the initial safety data and is concerned about any long term use. Prialt is one of the ones in the Pharma Marketing deal. I wonder if the company would be doing the additional trial if this were not the case. At this point, it seems hard to believe Prialt will amount to anything useful for Elan and its stockholders, of which I'm one.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next